Heat therapy combined with chemotherapy for advanced pancreatic cancer
Part of Cancer clinical trials.
This trial combines two treatments for advanced pancreatic cancer that hasn't spread: a special endoscopic procedure that uses heat to destroy cancer cells (radiofrequency ablation) and a standard chemotherapy drug combination (FOLFIRINOX). The goal is to see if this combination is safe and can help control the tumor better than chemotherapy alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 years or older
- Diagnosed with locally advanced, borderline resectable, or inoperable pancreatic cancer that has not spread to other organs (no metastases)
- No previous chemotherapy, radiation, or surgery for this cancer
- Must be in generally good physical condition (able to perform daily activities, rated 0 or 1 on the WHO scale)
- Must pass a screening to ensure the tumor is accessible via an ultrasound endoscope and you are safe for general anesthesia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of targeted radiation and two oral drugs (defactinib and avutometinib) for people with advanced pancreatic cancer that hasn't spread to distant organs. It may be an option if you've already had at least 2 months of chemo and your cancer is still locally advanced or borderline resectable.
This trial tests whether giving a strong chemotherapy combination (mFOLFIRINOX) together with radiation therapy can help people with advanced pancreatic cancer who have normal CA19-9 levels. It aims to see if this approach is more effective for this specific group of patients.
This trial tests a treatment that uses heat from a probe inserted through an endoscope to destroy pancreatic tumors that cannot be removed with surgery. It may help shrink or control the tumor and could be an option if other treatments have not worked.
This trial tests a procedure that uses sound waves to heat and destroy part of the tumor, combined with an immunotherapy drug called pembrolizumab (Keytruda) that helps your immune system fight the cancer. It is for people with pancreatic cancer that cannot be removed by surgery or has spread to other parts of the body.
This trial tests a procedure that uses an endoscope and ultrasound to heat (radiofrequency ablate) pancreatic neuroendocrine tumors. It may help shrink tumors while aiming to be a less invasive option.
This study is testing a new combination treatment that adds heat therapy to standard chemotherapy and radiation. The goal is to see if this approach can help shrink or control pancreatic tumors that haven't spread to other organs.
Hear when a new Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.